Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Japan |
First Approval Date01 May 2008 |
100 Clinical Results associated with Guangdong Otsuka Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Guangdong Otsuka Pharmaceutical Co., Ltd.
100 Deals associated with Guangdong Otsuka Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Guangdong Otsuka Pharmaceutical Co., Ltd.